Clinical Trial Update: The Role of Different Cycles of Chemotherapy（Capecitabine-oxaliplatin） in Esophageal Chemoradiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating different cycles of capecitabine-oxaliplatin chemotherapy in combination with chemoradiotherapy for Stage III esophag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Neoplasms
• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: The First Affiliated Hospital of Henan University of Science and Technology | Conditions: Stage III Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms | Phase 3 | Status: UNKNOWN